0000930413-14-000268.txt : 20140122 0000930413-14-000268.hdr.sgml : 20140122 20140122170718 ACCESSION NUMBER: 0000930413-14-000268 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20140117 FILED AS OF DATE: 20140122 DATE AS OF CHANGE: 20140122 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: ENZO BIOCHEM INC CENTRAL INDEX KEY: 0000316253 STANDARD INDUSTRIAL CLASSIFICATION: SERVICES-MEDICAL LABORATORIES [8071] IRS NUMBER: 132866202 STATE OF INCORPORATION: NY FISCAL YEAR END: 0731 BUSINESS ADDRESS: STREET 1: 60 EXECUTIVE BLVD CITY: FARMINGDALE STATE: NY ZIP: 11735 BUSINESS PHONE: 5167555500 MAIL ADDRESS: STREET 1: ENZO BIOCHEM INC STREET 2: 60 EXECUTIVE BLVD CITY: FARMINGDALE STATE: NY ZIP: 11735 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: RABBANI ELAZAR CENTRAL INDEX KEY: 0000903568 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-09974 FILM NUMBER: 14540846 4 1 c76254_form4.xml X0306 4 2014-01-17 0 0000316253 ENZO BIOCHEM INC ENZ 0000903568 RABBANI ELAZAR C/O ENZO BIOCHEM, INC. 527 MADISON AVENUE NEW YORK NY 10022 1 1 0 0 CEO Stock option (to acquire common stock) 2.70 2014-01-17 4 A 0 41634 0 A 2015-01-17 2019-01-17 Common Stock 41634 41634 D The Reporting Person was granted 41,634 options. The options have a five year term which shall vest in two equal installments, commencing on January 17, 2015. /s/ Elazar Rabbani, Ph. D. 2014-01-22